Siemens Archives - Page 2 of 2 - Medical Design Sourcing

Former Corindus CEO Toland joins robotic `micro’ surgical startup

Mark Toland, the former CEO of Corindus Vascular Robotics, believes the next big opportunity for surgical robotics is actually very small.

Toland, who sold the telesurgery robotics company to Siemens in 2019 for $1.1 billion, is now the CEO of Medical Microinstruments S.p.A. (MMI), an Italian company that has developed a surgical robotic system capable of performing microsurgery on capillaries, small vessels and other parts of the body existing robots – and maybe even surgeons – can’t reach.

“You see robotics companies that are trying to be the next Intuitive surgical or go after the laparoscopic surgery play,” Toland says. The objective “of this company is, `I want to create a field that doesn’t even exist today.’”

Founded in 2015 near Pisa, MMI in 2019 secured a CE-Mark for its Symani Surgical System to be used in open microsurgical procedures. The system already has been used in four surgical procedures in Florence, Italy including t…

Siemens Healthineers secures EUA for its COVID-19 antibody test

Siemens Healthineers (ETR: SHL) announced today that it has secured an FDA emergency use authorization for its COVID-19 antibody test.

The news comes nearly a week after the German medtech giant said it had started worldwide shipments of the test — a laboratory-based total antibody test that can detect SARS-CoV-2 antibodies including IgM and IgG in blood. The company already has more than 1 million tests shipped to health systems and laboratories.

Antibody tests are an important tool as countries reopen their economies amid the COVID-19 pandemic: They can tell who has had the coronavirus in the past and hopefully developed some immunity. Siemens Healthineers, in fact, designed its Total Antibody COV2T assay to detect antibodies to the spike protein, which are believed to neutralize the SARS-CoV-2 virus and therefore prevent infection.

“As a leader in laboratory diagnostics, Siemens Healthineers designed a high-quality, highly accurate antibody test with …

Siemens Healthineers to produce 50m antibody tests per month against COVID-19

Siemens Healthineers (ETR: SHL) said today that it has started worldwide shipments of its COVID-19 antibody test, with a goal of producing 50 million tests per month as the pandemic evolves.

The German medtech giant also announced that FDA has granted an emergency use authorization for its PCR Fast Track Diagnostics (FTD) SARS-CoV-2 Assay6 test kit.

Both types of tests are important: Antibody tests can tell who has had the coronavirus in the past and hopefully developed some immunity, while people need diagnostics tests to tell whether they are experiencing a COVID-19 infection right now.

Siemens officials say the company’s antibody tests demonstrate 100% sensitivity (ability to exclude false negatives) and 99.8% specificity (few false positives) in identifying SARS-CoV-2 antibodies in as few as 10 minutes. The tests have a CE Mark in the EU, and Siemens is seeking an FDA EUA.

Siemens boasts that it has 20,000 systems worldwide to run the t…